|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101.50 USD | -0.44% |
|
-7.92% | +6.62% |
| Capitalization | 21.96B 25.47B 19.82B 19.02B 34.68B 2,341B 36.3B 234B 93.88B 1,122B 95.59B 93.55B 4,014B | P/E ratio 2025 * |
-25.6x | P/E ratio 2026 * | -37.8x |
|---|---|---|---|---|---|
| Enterprise value | 11.25B 13.05B 10.15B 9.74B 17.77B 1,199B 18.59B 120B 48.09B 575B 48.96B 47.92B 2,056B | EV / Sales 2025 * |
4.18x | EV / Sales 2026 * | 4.35x |
| Free-Float |
86.48% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: BioNTech SE
| 1 day | -0.44% | ||
| 1 week | -7.92% | ||
| Current month | -7.92% | ||
| 1 month | -4.80% | ||
| 3 months | +5.45% | ||
| 6 months | -9.75% | ||
| Current year | +6.62% |
| 1 week | 97.22 |  | 110.1 |
| 1 month | 97.22 | | 112.68 |
| Current year | 95.85 | | 124 |
| 1 year | 81.2 | | 124 |
| 3 years | 76.53 | | 136.92 |
| 5 years | 76.53 | | 464 |
| 10 years | 12.52 | | 464 |
| Manager | Title | Age | Since |
|---|---|---|---|
Özlem Türeci
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/12/2017 |
Ugur Sahin
CEO | Chief Executive Officer | 60 | 01/06/2008 |
Sierk Poetting
DFI | Director of Finance/CFO | 53 | 31/08/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Helmut Jeggle
CHM | Chairman | 55 | 01/06/2008 |
| Director/Board Member | 69 | 01/06/2008 | |
| Director/Board Member | 65 | 31/12/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 2.92% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.44% | -7.92% | -8.42% | -22.84% | 25.47B | |
| -0.61% | -5.35% | +7.61% | +93.47% | 44.16B | |
| +0.92% | -4.81% | +49.57% | +13.78% | 40.5B | |
| -2.40% | -6.16% | +86.79% | +581.90% | 30.21B | |
| +2.54% | -9.65% | +54.31% | -36.52% | 19.22B | |
| -2.62% | -6.49% | +5.33% | -32.35% | 16.5B | |
| +5.20% | +0.37% | +49.24% | +146.95% | 12.64B | |
| +1.14% | -8.92% | -20.43% | +987.05% | 11.72B | |
| +4.43% | -0.31% | +53.50% | - | 11.51B | |
| +0.64% | -5.71% | +8.73% | +152.25% | 10.79B | |
| Average | +0.88% | -5.14% | +28.62% | +209.30% | 22.27B | |
| Weighted average by Cap. | +0.31% | -5.19% | +31.32% | +168.13% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.69B 3.12B 2.43B 2.33B 4.25B 287B 4.45B 28.73B 11.51B 138B 11.72B 11.47B 492B | 2.62B 3.04B 2.37B 2.27B 4.14B 280B 4.34B 28B 11.22B 134B 11.42B 11.18B 480B |
| Net income | -864M -1B -780M -748M -1.36B -92.07B -1.43B -9.22B -3.69B -44.15B -3.76B -3.68B -158B | -495M -574M -447M -429M -782M -52.79B -819M -5.29B -2.12B -25.32B -2.16B -2.11B -90.55B |
| Net Debt | -10.71B -12.42B -9.67B -9.28B -16.92B -1,142B -17.71B -114B -45.79B -548B -46.63B -45.63B -1,958B | -10.55B -12.24B -9.53B -9.14B -16.67B -1,125B -17.44B -113B -45.12B -539B -45.94B -44.96B -1,929B |
Employees
6,772
Calendar
03-10 -
Earnings release - Q4 2025
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/03/26 | 101.50 $ | -0.44% | 578,365 |
| 05/03/26 | 101.95 $ | -1.78% | 693,159 |
| 04/03/26 | 103.80 $ | +3.02% | 732,330 |
| 03/03/26 | 100.76 $ | -6.25% | 1,497,897 |
| 02/03/26 | 107.48 $ | -2.49% | 599,658 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
87.51EUR
Average target price
118.29EUR
Spread / Average Target
+35.17%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BNTX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition